GLP-1 Access Guides · Reviewed June 2026
GLP-1 access, state by state
Where Medicaid covers semaglutide and tirzepatide, where it doesn't, and how telehealth and compounding rules differ. Each guide is built from primary sources, not boilerplate, covering the 10 largest states by population with more on the way.
10 States
Browse by state
Most populous U.S. state
California
Adult obesity
29.1%
Diabetes
12.6%
2nd-most-populous state
Texas
Adult obesity
34.4%
Diabetes
13.5%
3rd-largest, fastest-growing state
Florida
Adult obesity
29.6%
Diabetes
11.6%
4th-largest state
New York
Adult obesity
29.5%
Diabetes
12.3%
5th-largest state
Pennsylvania
Adult obesity
34.2%
Diabetes
13.3%
6th-largest state
Illinois
Adult obesity
34.2%
Diabetes
12.8%
7th-largest state
Ohio
Adult obesity
36.9%
Diabetes
13.1%
8th-largest state
Georgia
Adult obesity
35.4%
Diabetes
12.8%
9th-largest state
North Carolina
Adult obesity
34.5%
Diabetes
13.2%
10th-largest state
Michigan
Adult obesity
36.1%
Diabetes
13.6%
Telehealth, any state
Personalized GLP-1 from US-licensed clinicians
No matter your state's coverage rules, Yucca Health offers a telehealth path to personalized GLP-1 treatment, from $129/mo.
See if you qualifySponsored · Affiliate disclosure
Educational information only, not medical or legal advice. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.